Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marco V Haselager

3PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 25, 2026
Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies.

|Jun 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

Simon Mobach, Nick D Bergkamp, Ziliang Ma

|Dec 23, 2022
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.

Marco V Haselager, Rachel Thijssen, Danique Bax

Pageof 1

Frequent Collaborators

3 joint publications

Eric Eldering

1 joint publications

Demi Both

1 joint publications

Anne Martens

1 joint publications

Ingrid Derks

1 joint publications

Arnon Kater

1 joint publications

Rachel Thijssen

1 joint publications

Simon Mobach

1 joint publications

Nick D Bergkamp

1 joint publications

Ziliang Ma

1 joint publications

Jelle van den Bor

Frequent Collaborators

3 joint publications

Eric Eldering

1 joint publications

Demi Both

1 joint publications

Anne Martens

1 joint publications

Ingrid Derks